Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

446

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

August 7, 2024

Study Completion Date

August 7, 2024

Conditions
Locally Advanced and Metastatic Solid Tumors
Interventions
DRUG

Ociperlimab

Administered as an intravenous (IV) injection

DRUG

Tislelizumab

Administered as an IV injection

DRUG

Pemetrexed

Administered in accordance with local guidelines, prescribing information/summary of product

DRUG

Paclitaxel

Administered in accordance with local guidelines , prescribing information/summary of product

DRUG

Nab paclitaxel

Administered in accordance with local guidelines , prescribing information/summary of product

DRUG

Carboplatin

Administered in accordance with local guidelines , prescribing information/summary of product

DRUG

Cisplatin

Administered in accordance with local guidelines , prescribing information/summary of product

DRUG

Etoposide

Administered in accordance with local guidelines , prescribing information/summary of product

DRUG

5fluorouracil

Administered in accordance with local guidelines , prescribing information/summary of product

DRUG

Oxaliplatin

Administered in accordance with local guidelines , prescribing information/summary of product

DRUG

Capecitabine

Administered in accordance with local guidelines , prescribing information/summary of product

Trial Locations (65)

970

Hualien Tzu Chi Hospital, Hualien City

1023

Auckland City Hospital, Auckland

2050

Chris Obrien Lifehouse, Camperdown

2148

Blacktown Cancer and Haematology Centre, Blacktown

3065

St Vincents Hospital, Fitzroy

3168

Monash Health, Clayton

3550

Bendigo Health, Bendigo

4101

Icon Cancer Foundation, South Brisbane

4102

Metro South Health, Cancer Trials Unit Division of Cancer Services Pah, Woolloongabba

4217

Pindara Private Hospital, Benowa

5087

Ashford Cancer Centre Research Northeast, Windsor Gardens

6008

St John of God Health Care, Subiaco

6009

Linear Clinical Research, Nedlands

7000

Royal Hobart Hospital, Hobart

8011

Nzcr Christchurch, Christchurch

10048

National Taiwan University Hospital, Taipei

10408

National Cancer Center, Goyang-si

11217

Taipei Veterans General Hospital, Taipei

13620

Seoul National University Bundang Hospital, Seongnam-si

16247

The Catholic University of Korea, St Vincents Hospital, Suwon

21565

Gachon University Gil Medical Center, Incheon

32224

Mayo Clinic Jacksonville, Jacksonville

33305

Linkou Chang Gung Memorial Hospital, Taoyuan District

33705

Scri Florida Cancer Specialists North, St. Petersburg

33901

Scri Florida Cancer Specialists South, Fort Myers

37203

Tennessee Oncology, Pllc Nashville, Nashville

40201

Chung Shan Medical University Hospital, Taichung

40447

China Medical University Hospital, Taichung

40705

Veterans General Hospital Taichung, Taichung

52727

Gyeongsang National University Hospital, Jinju

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic Rochester, Rochester

66160

University of Kansas Medical Center Research Institute, Kansas City

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

85254

Mayo Clinic Phoenix, Phoenix

97213

Providence Portland Medical Center, Portland

100010

Beijing Tongren Hospital, Cmu, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

100142

Beijing Cancer Hospital, Beijing

101149

Beijing Luhe Hospital, Capital Medical University, Beijing

130021

Jilin Cancer Hospital, Changchun

150000

Harbin Medical University Cancer Hospital, Harbin

200030

Shanghai Chest Hospital, Shanghai

230601

The Second Hospital of Anhui Medical University, Hefei

231405

Taipei Tzu Chi Hospital, Taipei

250013

Jinan Central Hospital, Jinan

261000

Weifang Peoples Hospital, Weifang

300052

Tianjin Medical University General Hospital, Tianjin

300060

Tianjin Medical University Cancer Institute and Hospital, Tianjin

310022

Zhejiang Cancer Hospital, Hangzhou

350014

Fujian Cancer Hospital, Fuzhou

400030

Chongqing Cancer Hospital, Chongqing

410013

Hunan Cancer Hospital, Changsha

430022

Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan

430079

Hubei Cancer Hospital, Wuhan

450000

Henan Cancer Hospital, Zhengzhou

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

510515

Nanfang Hospital of Southern Medical University, Guangzhou

610041

Sichuan Cancer Hospital and Institute, Chengdu

710061

The First Affiliated Hospital of Xian Jiaotong University, Xi'an

08901

Rutgers Cancer Institute of New Jersey, New Brunswick

03722

Severance Hospital Yonsei University Health System, Seoul

06591

The Catholic University of Korea, Seoul St Marys Hospital, Seoul

07061

Smg Snu Boramae Medical Center, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeiGene

INDUSTRY

NCT04047862 - Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | Biotech Hunter | Biotech Hunter